This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Honeywell International (HON) Outperforming Other Conglomerates Stocks This Year?
by Zacks Equity Research
Is (HON) Outperforming Other Conglomerates Stocks This Year?
Honeywell (HON) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Honeywell (HON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Honeywell (HON) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Honeywell (HON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Strong Earnings and Retail Sales Data
by Zacks Equity Research
Strong Earnings and Retail Sales Data
Honeywell (HON) Q1 Earnings & Revenues Outpace Estimates
by Zacks Equity Research
Solid long-cycle businesses in U.S. defense, commercial aerospace, and warehouse and process automation drive Honeywell's (HON) Q1.
Q1 Earnings Continue to Impress, Retail Sales Hit 18-Month High,
by Swarup Gupta
Investors will welcome a massive jump in retail sales even as first-quarter results continue to roll in.
5 Earnings Charts to Watch for Recession Clues
by Tracey Ryniec
Worried about the US economy? These companies have their finger on the pulse of the economy through the transports, construction, lending, manufacturing and retail.
Honeywell (HON) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Honeywell's (HON) strength in commercial aerospace and process solutions businesses as well as solid demand for commercial fire products will be conducive to Q1 results. Rising costs pose a concern.
Honeywell (HON) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Honeywell (HON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern
Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).
KushCo (KSHB) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
KushCo' (KSHB) second-quarter fiscal 2019 earnings are likely to gain from solid product demand, international expansion and improving operational excellence. Supply-chain capacity issues are concerning.
Why Honeywell (HON) Could Beat Earnings Estimates Again
by Zacks Equity Research
Honeywell (HON) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Honeywell's Technology Chosen by Jiangsu Sailboat in China
by Zacks Equity Research
Jiangsu Sailboat selects Honeywell's (HON) C3 Oleflex technology for the production of polymer-grade propylene at its facility in China.
Honeywell (HON) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Honeywell (HON) closed at $155.04 in the latest trading session, marking a +1% move from the prior day.
Honeywell's Technology Chosen by Phu My Plastics Production
by Zacks Equity Research
Phu My Plastics Production selects Honeywell's (HON) C3 Oleflex technology for the production of polymer-grade propylene at its facility in Vietnam.
The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources
Honeywell (HON) Launches Operational Intelligence Solution
by Zacks Equity Research
Honeywell's (HON) Honeywell Operational Intelligence solution helps companies to streamline IT processes and reduce technology expenses.
Top Stock Reports for Visa, Honeywell & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Honeywell (HON) and Biogen (BIIB).
Honeywell Opens Online Store to Improve Access to Solutions
by Zacks Equity Research
Honeywell's (HON) online application store offers software like push-to-talk communications and medical tracking for hospital industry, and asset tracking, point-of-sale software for retail industry.
Honeywell (HON) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Honeywell (HON) closed at $154.03, marking a +0.54% move from the previous day.
Industrial ETFs Stay Strong Despite Mixed Earnings
by Sanghamitra Saha
Signs of improvement in trade relations between the United States and China and the Fed???s dovish stance have helped industrial ETFs despite mixed earnings.
The Zacks Analyst Blog Highlights: Raytheon, Northrop, TransDigm, Spirit and Honeywell
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Raytheon, Northrop, TransDigm, Spirit and Honeywell
Defense Stock Roundup: Q4 Results Impress, RTN, NOC, TDG Earnings Top
by Zacks Equity Research
Over the past five trading sessions, the defense biggies put up a solid show. Notably,the S&P 500 Aerospace & Defense (Industry) and the Dow Jones U.S. Aerospace & Defense index gained 3.3%.
Honeywell (HON) & Curtiss-Wright to Boost Aviation Safety
by Zacks Equity Research
Honeywell's (HON) deal with Curtiss-Wright to develop a new generation of cockpit voice and flight-data recorders will help investigators ascertain accident cause, thereby making aviation safer.